SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of a major industry shift following news that it will acquire Boeings Wisk Aero, SkyGrid, and Insitu units, a deal that includes a nearly 20% equity stake from Boeing and provides Archer with a established defense revenue stream. While the community is actively debating the implications of potential dilution against the benefits of these new assets, the stock remains a focal point for investors weighing its long-term aerospace platform potential against near-term certification risks.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as investors digest a major expansion of its U.S. manufacturing footprint alongside strong institutional backing, fueling optimism around its pivotal role in the AI optical networking bottleneck. The community is actively debating the sector's long-term growth potential and the impact of potential trade restrictions on Chinese optical components as demand for high-speed connectivity scales.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating significant market discussion as investors anticipate topline Phase 3 IZAR-1 data, with community sentiment split between frustration over timing delays and high conviction in the drug's long-term potential. While the stock faces volatility and bearish short-term pressure, many retail and institutional holders remain focused on the broader multi-indication strategy and potential for a strategic exit if trial results validate its efficacy profile.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings ($LITE) is trending as investors weigh its critical role in AI optical infrastructure against broader market volatility and sector-wide repricing. While the community remains divided on whether recent price action is a healthy correction within a long-term AI supercycle or a sign of an overextended bubble, sentiment remains anchored on the company's laser chip leadership and supply-demand imbalances in the photonics supply chain.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending following the announcement of a strategic collaboration with Vertex Pharmaceuticals, a move that reinforces the credibility of its proprietary T-cell engager platform alongside recent partnerships. Community sentiment remains highly divided between long-term investors focused on platform validation and clinical progress toward upcoming Phase 2 data readouts, and skeptics who remain frustrated by the stock's multi-year price decline and perceived management underperformance.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors digest a strong earnings report showing a double-digit rise in operating profit and a strategic pivot from net seller to net buyer of equities. While some community members remain frustrated by the stock's long-term price stagnation and lack of dividends, others are highlighting the company's massive cash deployment and defensive value as key catalysts for potential upside.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Airbnb is trending as investors weigh strong travel momentum and potential World Cup bookings against concerns over regulatory headwinds and a competitive landscape. While the company faces pressure from increasing local short-term rental restrictions, the community is heavily focused on whether AI-driven product innovation and expansion into broader travel services will sustain long-term growth.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is seeing increased volatility as investors weigh strong earnings and AI-driven growth against concerns over high valuations and acquisition-related costs. The community remains divided, with many traders debating whether to buy the dip during this pullback or lock in profits after the stock's significant run-up to all-time highs.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending as investors weigh significant AI-driven demand for high-speed optical transceivers against volatility and speculative short-selling activity. The community is actively debating the company's manufacturing capacity expansion and revenue growth potential ahead of critical earnings reports.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer is experiencing significant volatility and retail frustration as investors weigh its aggressive expansion into AI and high-performance computing infrastructure against recent earnings results and a large capital offering. While the community remains divided over the stock's sluggish price action compared to sector peers, discussions are heavily focused on its massive long-term data center contracts and the potential for a valuation re-rating as the company pivots away from pure-play crypto mining.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Skip to main content

Yahoo Finance
Earnings coming premarket normally bullish 

$RGC $MRK $PFE $MRNA 

Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026

PR Newswire

Mon, August 10, 2026 at 7:30 AM EDT 2 min read

KPTI

+8.72%

Caregiver Resources &amp; SupportPA Health and Wellness•

Ad

-- Conference Call Scheduled for Thursday, August 13, 2026, at 8:00 a.m. ET --

NEWTON, Mass., Aug. 10, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report second quarter 2026 financial results on Thursday, August 13, 2026. Karyopharm&#39;s management team will host a conference call and audio webcast at 8:00 a.m. ET on Thursday, August 13, 2026, to discuss the financial results and other company 

https://www.prnewswire.com/news-releases/karyopharm-to-report-second-quarter-2026-financial-results-on-august-13-2026-302845213.html

PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it...

Prnewswire

Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026

StockTwits For Android 

Regencell Bioscience Holdings Ltd

Merck & Co Inc

Pfizer Inc

Moderna Inc

Skip to main content

Yahoo Finance
Earnings coming premarket normally bullish 



 

Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026

PR Newswire

Mon, August 10, 2026 at 7:30 AM EDT 2 min read

KPTI

+8.72%

Caregiver Resources & SupportPA Health and Wellness•

Ad

-- Conference Call Scheduled for Thursday, August 13, 2026, at 8:00 a.m. ET --

NEWTON, Mass., Aug. 10, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report second quarter 2026 financial results on Thursday, August 13, 2026. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Thursday, August 13, 2026, to discuss the financial results and other company 

